Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yelena Levina

Hand Surgery Macon, GA Medical Doctor

NPI 1619323524 CMS profile 7228281

3708 Northside Dr, Macon, GA 31210

Open in the dashboard

General payments

$14,570

55 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Yelena Levina of Macon, GA is reported in the CMS Open Payments database as having received $14,570 across 55 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $80 2
2023 General $58 2
2022 General $5,510 33
2021 General $6,279 15
2020 General $1,611 2
2019 General $1,032 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yelena Levina
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Yelena Levina were reported at $80. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Yelena Levina Hand Surgery median Middle half National median
2019 $1,032 $383 $106–$1,905 $163
2020 $1,611 $172 $51–$1,268 $114
2021 $6,279 $263 $71–$1,591 $132
2022 $5,510 $336 $87–$1,938 $149
2023 $58 $233 $81–$1,114 $160
2024 $0 $258 $88–$1,203 $164
2025 $80 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AxoGen $4,954 12 payments
  2. Arthrex, Inc. $3,080 16 payments
  3. MVP Orthopedics Inc $2,711 7 payments
  4. United Orthopedics LLC $2,643 3 payments
  5. Stryker Corporation $360 4 payments
  6. DePuy Synthes Sales Inc. $182 4 payments
  7. Endo Pharmaceuticals Inc. $145 2 payments
  8. Sonex Health, Inc. $137 1 payment
  9. ExsoMed Corporation $97 1 payment
  10. Checkpoint Surgical, Inc $88 1 payment
  11. Other $173 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $7,443 7 payments
  2. Travel and Lodging $4,201 5 payments
  3. Food and Beverage $2,926 43 payments
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $4,954 12 payments
  2. VARIAX $324 3 payments
  3. BIO4 $163 1 payment
  4. REUNION $163 1 payment
  5. XIAFLEX $145 2 payments
  6. VA-LCP $143 3 payments
  7. ULTRAGUIDECTR $137 1 payment
  8. ULTRAGUIDETFR $137 1 payment
  9. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE IB LIGAMENT AUGMENTATION $104 1 payment
  10. DISTAL EXTREMITIES IMPLANTS TRAUMA MINI FRAGMENT $97 1 payment
  11. Other $889 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

334

Median for Orthopedic Surgery: 203

Drug cost

$1,569

Median for Orthopedic Surgery: $1,433

Branded share of claims

21.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ibuprofen Generic 43 $585
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 71 $320
Cephalexin Generic 70 $194
Ondansetron Hcl Generic 66 $185
Methylprednisolone Generic 19 $135
Meloxicam Generic 49 $122
Tramadol Hcl Generic 16 $27

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 83 billing codes

Paid by Medicare

$69,680

Of which drugs: $2,427

Medicare patients

237

Average age 74

Services billed

1,578

155 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Diabetes 33%
Chronic kidney disease 33%
Depression 30%
Ischemic heart disease 27%
Osteoporosis 22%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 85 279 $1,416

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

55 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record